Aspirin as a New Treatment for Osteoporosis in Mice
Author Information
Author(s): Yamaza Takayoshi, Miura Yasuo, Bi Yanming, Liu Yongzhong, Akiyama Kentaro, Sonoyama Wataru, Patel Voymesh, Gutkind Silvio, Young Marian, Gronthos Stan, Le Anh, Wang Cun-Yu, Chen WanJun, Shi Songtao
Primary Institution: University of Southern California School of Dentistry
Hypothesis
Does aspirin regulate the balance between bone resorption and bone formation at stem cell levels in osteoporosis?
Conclusion
Aspirin may serve as a new alternative treatment for osteoporosis by improving bone formation and inhibiting bone resorption.
Supporting Evidence
- Aspirin treatment improved bone density in ovariectomized mice.
- Aspirin inhibited T cell activation and BMMSC apoptosis.
- Aspirin increased osteogenesis of BMMSCs.
- Aspirin reduced osteoclast activity in OVX mice.
- Aspirin treatment elevated telomerase activity in BMMSCs.
Takeaway
This study found that aspirin can help bones stay strong by stopping certain cells from dying and helping other cells grow.
Methodology
The study used ovariectomized mice to test the effects of aspirin on bone density and stem cell function.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Ovariectomized mice were used as the model for osteoporosis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website